Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.994 SEK | +2.26% | +1.95% | +44.27% |
Sales 2024 * | 266M 24.85M | Sales 2025 * | 136M 12.67M | Capitalization | 654M 61.07M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | -72M -6.72M | EV / Sales 2024 * | 1.34 x |
Net cash position 2024 * | 297M 27.73M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.82 x |
P/E ratio 2024 * |
-1.87
x | P/E ratio 2025 * |
-3.12
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.64% |
Latest transcript on Alligator Bioscience AB
1 day | +2.26% | ||
1 week | +1.95% | ||
Current month | -10.45% | ||
1 month | -10.61% | ||
3 months | +42.20% | ||
6 months | +140.39% | ||
Current year | +44.27% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 21-05-31 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 20-08-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graham Dixon
BRD | Director/Board Member | 63 | 19-05-08 |
Chairman | 70 | 16-12-31 | |
Staffan Encrantz
BRD | Director/Board Member | 73 | 22-05-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.994 | +2.26% | 700,077 |
24-03-27 | 0.972 | -1.02% | 1,522,143 |
24-03-26 | 0.982 | -0.51% | 1,205,807 |
24-03-25 | 0.987 | -1.50% | 1,197,260 |
24-03-22 | 1.002 | +2.77% | 1,376,463 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+44.27% | 61.21M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |